SIMULECT

Google image searchProduct monograph

Active ingredient

basiliximab, 20 MG/VIAL

DIN: 02242815

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription / Schedule D

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 23-OCT-2000

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AC — Interleukin inhibitors (ATC, ATC/DDD)
• L04AC02 — BASILIXIMAB (ATC/DDD)

Reference brand drug: Simulect

Pharmaceutical standard: MFR

External Links for Simulect

Search on Google

• Simulect side effects
• Simulect dosage
• basiliximab side effects
• basiliximab dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find simulect photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.